Maravai LifeSciences Holdings, Inc. (MRVI)

NMS – Real Time Price. Currency in USD

5.82

+0.01 (0.26%)

Market open: Aug 12, 2026, 2:13 PM EDT

5.81

0.00 (0.00%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Stock details

Previous close: 5.81$
Day's range: 5.73 - 6.18$
52-week range: 2.28 - 7.44$
Volume: 2 424 129
Average volume: 1 934 361
Beta: 0.71
EPS (TTM): -0.53
PE ratio (TTM): N/A
Forward P/E: N/A
Market cap: 1 500 084 753
Shares outstanding: 258 190 147
Dividend yield: N/A
Next earnings date: 2026-11-05
Sector: Healthcare
Industry: Biotechnology

About the company

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products that enable the development of drug therapies, vaccines, drug therapies, cell and gene therapies, and diagnostics North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin and Central America. It operates through two segments: TRILINK and CYGNUS. The TRILINK segment manufactures and sells products for use in the fields of gene th... read more

CEO: Bernd Brust
Country: United States
IPO Date: 2020-11-20
Employees: 416
Fiscal Year End: January - December
Website: https://www.maravai.com

Revenue Breakdown

TriLink / 64.49%

Cygnus / 35.51%

News

No Data

There are no news for this stock.

Chart: MRVI

Loading Chart...

Overall Score

2.6 / 1026%

Octagon View

Strength & Weakness

Cash reserves $0.0 barely cover the upcoming debt maturities $0.0

Total current assets $0.0 are just enough to cover Total current liabilities $0.0, indicating tight liquidity

Debt-to-equity ratio (0.0) is near the industry average, reflecting balanced leverage

Interest coverage ratio (-3.1x) is dangerously low, suggesting debt repayment risks

Financial Strength

NAME	RATIO	INDUSTRY	SCORE
Current ratio	N/A	6.05	1.0
Quick ratio	N/A	5.63	1.0
Debt to Equity	N/A	0.30	1.0
Debt to Assets	N/A	1.04	1.0
Interest coverage	-3.14	-16.91	1.0
Weighted average score			1.0

Debt to Assets

Financial

Values in USD
(B=Billions, M=Millions, K=Thousands)

Values in USD (B=Billions, M=Millions, K=Thousands)

METRIC	2022	2023	2024	2025	TTM
Total Revenue	883M	289M	259M	186M	209M
Gross Profit	711M	138M	106M	31M	72M
Operating Income	586M	-4M	-63M	-96M	-28M
Net Income	220M	-119M	-145M	-131M	-77M
EBITDA	624M	45M	-6M	-36M	27M

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

NAME	RATIO	INDUSTRY	SCORE
Gross margin %	40.14	-11.73	8.0
Operating margin %	-29.40	-24.60	1.0
Net margin %	-24.14	-172.20	1.0
EBITDA margin %	-6.49	-201.27	1.0
Cash flow margin %	N/A	-156.39	1.0
Weighted average score			2.4

Net Margin

Effectiveness

NAME	RATIO	INDUSTRY	SCORE
ROA	-13.80	-57.97	1.0
ROE	-46.49	-63.56	1.0
ROIC	-20.11	-42.57	1.0
ROCE	-1.28	-71.10	1.0
Weighted average score			1.0

Estimated EPS vs Actual EPS

Forecast

NAME	REVENUE GROWTH	EPS GROWTH	SCORE
Current quarter	7.46	33.45	7.5
Next quarter	1.58	-8.25	2.0
Current year	13.91	64.6	9.0
Next year	6.7	22.8	7.5
Weighted average score			6.5

Analyst Rating

Growth

NAME	REVENUE	NET INCOME	EPS	FCF	SCORE
Q/Q	-21.85	-232.59	-299.99	116.99	3.3
Y/Y	8.53	68.64	75	130.44	9.0
3y average	-35.29	-55.32	-240.53	-142.89	1.0
5y average	17.18	-1.64	-105.18	-40.59	3.0
Weighted average score					4.1

Revenue Growth Rate vs. Industry

Valuation

NAME	RATIO	INDUSTRY	SCORE
P/E	28.33	-5.25	4.0
PEG (5yr expected)	N/A	0.27	1.0
P/S	4.24	64.66	6.4
P/B	4.41	2.96	3.6
Weighted average score			3.8

DCF Model

DCF Model Period5 years

Discount rate8.5%

Perpetual growth rate3%

Revenue 5 year CAGR12.52%

FCF 5 year CAGR4

Fair value4.52$

Stock price5.81$

Dividend

NAME	CURRENT	INDUSTRY	SCORE
Dividend yield	0.00	N/A	1.0
Payout ratio	0.00	N/A	1.0
5-year dividend growth rate	N/A	N/A	1.0
Years of dividend increase	N/A	N/A	1.0
Weighted average score			1.0

Fair Value

$4.52

UndervaluedStock priceOvervalued

$5.81

Economic Moat

NAME	SCALE	SCORE
Market share	None	1.0
Intangible assets	None	1.0
Switching costs	None	1.0
Network effect	None	1.0
Economies of scale	None	1.0
Weighted average score		1.0

About the company

CEO

Bernd Brust

Country

United States

IPO Date

2020-11-20

Employees

416

Fiscal Year End

January - December

Website

https://www.maravai.com

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

Current ratio

N/A

6.05

1.0

Quick ratio

N/A

5.63

1.0

Debt to Equity

N/A

0.30

1.0

Debt to Assets

N/A

1.04

1.0

Interest coverage

-3.14

-16.91

1.0

Weighted average score

1.0

METRIC

2022

2023

2024

2025

TTM

Total Revenue

883M

289M

259M

186M

209M

Gross Profit

711M

138M

106M

31M

72M

Operating Income

586M

-4M

-63M

-96M

-28M

Net Income

220M

-119M

-145M

-131M

-77M

EBITDA

624M

45M

-6M

-36M

27M

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

Gross margin %

40.14

-11.73

8.0

Operating margin %

-29.40

-24.60

1.0

Net margin %

-24.14

-172.20

1.0

EBITDA margin %

-6.49

-201.27

1.0

Cash flow margin %

N/A

-156.39

1.0

Weighted average score

2.4

NAME

RATIO

INDUSTRY

5Y TREND

SCORE

ROA

-13.80

-57.97

1.0

ROE

-46.49

-63.56

1.0

ROIC

-20.11

-42.57

1.0

ROCE

-1.28

-71.10

1.0

Weighted average score

1.0

NAME

REVENUE GROWTH

EPS GROWTH

SCORE

Current quarter

7.46

33.45

7.5

Next quarter

1.58

-8.25

2.0

Current year

13.91

64.6

9.0

Next year

6.7

22.8

7.5

Weighted average score

6.5

NAME

REVENUE

NET INCOME

EPS

FCF

SCORE

Q/Q

-21.85

-232.59

-299.99

116.99

3.3

Y/Y

8.53

68.64

130.44

9.0

3y average

-35.29

-55.32

-240.53

-142.89

1.0

5y average

17.18

-1.64

-105.18

-40.59

3.0

Weighted average score

4.1

NAME

RATIO

INDUSTRY

5Q TREND

SCORE

P/E

28.33

-5.25

4.0

PEG (5yr expected)

N/A

0.27

1.0

P/S

4.24

64.66

6.4

P/B

4.41

2.96

3.6

Weighted average score

3.8

NAME

CURRENT

INDUSTRY

SCORE

Dividend yield

0.00

N/A

1.0

Payout ratio

0.00

N/A

1.0

5-year dividend growth rate

N/A

1.0

Years of dividend increase

N/A

1.0

Weighted average score

1.0

NAME

SCALE

SCORE

Market share

None

1.0

Intangible assets

None

1.0

Switching costs

None

1.0

Network effect

None

1.0

Economies of scale

None

1.0

Weighted average score

1.0

Search stocks

Maravai LifeSciences Holdings, Inc. (MRVI)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

Maravai LifeSciences Holdings, Inc. (MRVI)

Stock details

About the company

Revenue Breakdown

News

Chart: MRVI

Overall Score

Octagon View

Strength & Weakness

Financial Strength

Debt to Assets

Financial

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

Net Margin

Effectiveness

Estimated EPS vs Actual EPS

Forecast

Analyst Rating

Growth

Revenue Growth Rate vs. Industry

Valuation

DCF Model

Dividend

Fair Value

$4.52

$5.81

Economic Moat

Stock details

About the company

Revenue Breakdown

News

Chart: MRVI

Overall Score

Octagon View

Strength & Weakness

Financial Strength

Debt to Assets

Financial

Current Ratio

Revenue & Net Income

Cashflow

Margin Ratios

Profitability

Net Margin

Effectiveness

Estimated EPS vs Actual EPS

Forecast

Analyst Rating

Growth

Revenue Growth Rate vs. Industry

Valuation

DCF Model

Dividend

Fair Value

$4.52

$5.81

Economic Moat